| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diabetes > How The Pancreas Produces Insulin |
|
Advice Pool - How The Pancreas Produces Insulin
The pancreas is an organ located below the breastbone, close to the stomach and duodenum. It's principle responsibility is to create digestive enzymes and hormo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nes, one of which is insulin. This article will describe how insulin is created in the pancreas and the other hormones that help to modify the blood sugar level ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in of the body. The pancreas is made up of exocrine and endocrine cells. Exocrine cells create the digestive enzymes that are passed into the stomach to help bre lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ak down food. Endocrine cells are responsible for creating and secreting insulin and it's counterpart glucagon. These hormones are responsible for controlling here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he level of glucose in the blood at any one time. Glucose is effectively the energy that keeps the cells in the body functioning. Without glucose the body woul d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro starve. Glucose is absorbed from food via the stomach. The bloodstream passes glucose to all the cells in the body. Endocrine cells are made up of pancreatic ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc islets or Islets of Langerhans (after Paul Langerhans, who discovered them in 1869). Within the pancreatic islets are many smaller cells. Two of these cells pro easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi uce the hormones insulin and glucagon. The beta cells create and secrete insulin. The alpha cells create and secrete glucagon. These two hormones are respons nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ble for maintaining the glucose level in blood at a constant rate so that all the cells have the required energy to perform their functions. They tend to work i and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n an on/off relationship. When insulin is being secreted, glucagon is absent and vice versa. The process starts when someone has eaten food. As the food is dig ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sted, glucose is passed into the bloodstream and distributed throughout the body. This glucose is used by the body to function normally but if there is any gluc ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a se left over or too much glucose in the bloodstream, the pancreas secretes insulin. Insulin has the effect of acting on many cells in the body to create glycog dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod en. Glycogen is a form of storage for glucose in cells. It is an emergency reserve of glucose in cellular form should the body need it. The principal cells that cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin insulin works on are the liver, fat and muscle cells. Thus glycogen is stored in these cells. This has the effect of keeping the glucose level in the blood to a tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen constant and normal level. As the food has been absorbed and energy is used by the cells there will come a time when the blood sugar levels get low. This means t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the cells could be starved of energy and not work effectively. This might occur when somebody is sleeping or dieting. When the blood sugar level is low, gluca ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust on is created and secreted. It acts on the same cells that insulin works on, notably the liver, fat and muscle cells but instead of creating glycogen it convert y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products glycogen into glucose. The glucose can then by used by the body's cells to continue functioning via the bloodstream. In this way the blood sugar level can alwa . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ys remain constant whether the body is processing food or not. The pancreas is responsible for ensuring this delicate process continues seamlessly. It is only elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip hen the pancreas starts to malfunction that people become aware of the vital role it plays in providing energy to the body and keeping blood sugar levels normal tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Counterfeit Wines Leave Bad Taste for Chicago Trademark Lawyer - Recalling Ersatz Pine-Sol How to be Comfortable on a First Date Learn Manicure and Pedicure at Home
|